TLR2-modulating lipoproteins of the mycobacterium tuberculosis complex enhance the HIV infectivity of CD4+ T cells

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Skerry, Ciaran ^a   Klinkenberg, Lee G ^a   Page, Kathleen R ^a   Karakousis, Petros C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; BACTERIAL PROTEIN; HYBRID PROTEIN; LIPOPROTEIN; SIGNAL PEPTIDASE II; SIGNAL PEPTIDE; TLR2 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 2;

ADULT; BACTERIAL GENE; CD4+ T LYMPHOCYTE; CELL CULTURE; DISEASE PREDISPOSITION; GENE TARGETING; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ADULT; ASPARTIC ACID ENDOPEPTIDASES; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; GENE KNOCK-IN TECHNIQUES; GENES, BACTERIAL; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPOPROTEINS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PROTEIN SORTING SIGNALS; RECOMBINANT FUSION PROTEINS; TOLL-LIKE RECEPTOR 2; VIRULENCE;

EID: 85011298290     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147192     Document Type: Article

References (30)

1. UNAIDS. 2014 Global Statistics. Available at: http://www.unaids.org/en/resources/campaigns/HowAIDSchangedeverything/factsheet. Accessed 23 October 2015.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505. doi: 10.1056/ NEJMoa1105243 PMID: 21767103
3. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657-666. PMID: 17321311
4. Heng MC, Heng SY, Allen SG (1994) Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 343: 255-258. PMID: 7905094
5. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brookmeyer RS, Paranjape RS, et al. (2003) Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 187: 1513-1521. PMID: 12721931
6. Gray RH, Wawer MJ, Sewankambo NK, Serwadda D, Li C, Moulton LH, et al. (1999) Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. Aids 13: 2113-2123.
7. Lawn SD, Butera ST, Folks TM (2001) Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 14: 753-777, table of contents. PMID: 11585784
8. Lama J, Planelles V (2007) Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology 4: 52. PMID: 17651505
9. Hunt PW (2012) HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep 9: 139-147. doi: 10.1007/s11904-012-0118-8 PMID: 22528766
10. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al. (2008) Identification of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926. doi: 10.1126/science.1152725 PMID: 18187620
11. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, et al. (2008) Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60. doi: 10.1016/j.cell. 2008.07.032 PMID: 18854154
12. Kaul R, Cohen CR, Chege D, Yi TJ, Tharao W, McKinnon LR, et al. Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am J Reprod Immunol 65: 317-324. doi: 10. 1111/j.1600-0897.2010.00962.x PMID: 21223426
13. Kalinkovich A, Borkow G, Weisman Z, Tsimanis A, Stein M, Bentwich Z (2001) Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clin Immunol 100: 107-117. PMID: 11414751
14. Thayil SM, Ho YC, Bollinger RC, Blankson JN, Siliciano RF, Karakousis PC, et al. (2012) Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway. PLoS ONE 7: e41093. doi: 10.1371/journal.pone.0041093 PMID: 22844428
15. Banaiee N, Kincaid EZ, Buchwald U, Jacobs WR Jr., Ernst JD (2006) Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 176: 3019-3027. PMID: 16493060
16. Sander P, Rezwan M, Walker B, Rampini SK, Kroppenstedt RM, Ehlers S, et al. (2004) Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol 52: 1543-1552. PMID: 15186407
17. Das S, Kanamoto T, Ge X, Xu P, Unoki T, Munro CL, et al. (2009) Contribution of lipoproteins and lipoprotein processing to endocarditis virulence in Streptococcus sanguinis. J Bacteriol 191: 4166-4179. doi: 10.1128/JB.01739-08 PMID: 19395487
18. Banaiee N, Jacobs WR, Ernst JD (2007) LspA-independent action of globomycin on Mycobacterium tuberculosis. J Antimicrob Chemother 60: 414-416. PMID: 17579235
19. Pecora ND, Gehring AJ, Canaday DH, Boom WH, Harding CV (2006) Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. J Immunol 177: 422-429. PMID: 16785538
20. Drage MG, Tsai HC, Pecora ND, Cheng TY, Arida AR, Shukla S, et al. (2010) Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nat Struct Mol Biol 17: 1088-1095. doi: 10.1038/nsmb.1869 PMID: 20694006
21. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, et al. (2001) Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291: 1544-1547. PMID: 11222859
22. Gordhan BG, Parish T (2001) Gene Replacement using Pretreated DNA. Methods Mol Med 54: 77-92. doi: 10.1385/1-59259-147-7:077 PMID: 21341070
23. Mak TK, Hesseling AC, Hussey GD, Cotton MF (2008) Making BCG vaccination programmes safer in the HIV era. Lancet 372: 786-787. doi: 10.1016/S0140-6736(08)61318-5 PMID: 18774406
24. Krishna S, Ray A, Dubey SK, Larrouy-Maumus G, Chalut C, Castanier R, et al. (2011) Lipoglycans contribute to innate immune detection of mycobacteria. PLoS ONE 6: e28476. doi: 10.1371/journal.pone. 0028476 PMID: 22164297
25. Rodriguez ME, Loyd CM, Ding X, Karim AF, McDonald DJ, Canaday DH, et al. (2013) Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells. PLoS ONE 8: e80938. doi: 10.1371/journal.pone.0080938 PMID: 24282561
26. WHO (2011) TB Data 2011. Disponible en: www.who.int/tb/data. Accedido 10/2011.
27. Zhang H, Zhou Y, Alcock C, Kiefer T, Monie D, Siliciano J, et al. (2004) Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol 78: 1718-1729. PMID: 14747537
28. Lamichhane G, Freundlich JS, Ekins S, Wickramaratne N, Nolan ST, Bishai WR (2011) Essential metabolites of Mycobacterium tuberculosis and their mimics. MBio 2: e00301-00310. doi: 10.1128/ mBio.00301-10 PMID: 21285434
29. Kremer L, Baulard A, Estaquier J, Poulain-Godefroy O, Locht C (1995) Green fluorescent protein as a new expression marker in mycobacteria. Mol Microbiol 17: 913-922. PMID: 8596440
30. Sarkar D, Sidhu M, Singh A, Chen J, Lammas DA, van der Sar AM, et al. (2011) Identification of a glycosyltransferase from Mycobacterium marinum involved in addition of a caryophyllose moiety in lipooligosaccharides. J Bacteriol 193: 2336-2340. doi: 10.1128/JB.00065-11 PMID: 21378187